Biogen and AbbVie Receive Positive Opinion from the CHMP on ZINBRYTA™ (Daclizumab) for Treatment of Multiple Sclerosis Biotech Investing
CORRECTING and REPLACING Sucampo Standardizes on Veeva Vault for a Single Source of Truth and Enterprise-wide Capability Biotech Investing
Your.MD Launches “OneStop Health” – the First AI Recommendation Solution to Find Public and Private Health Services and Products Biotech Investing
Aduro Biotech Announces Key Preclinical Data Published Highlighting New Approach to Treat Multiple Myeloma Biotech Investing
XOMA Initiates XOMA 358 Proof-of-Concept Study in Patients with Hypoglycemia Post Gastric Bypass Surgery Biotech Investing
Agenus Commences Phase 1 Clinical Trial of its CTLA-4 Checkpoint Antibody to Treat Solid Tumors Biotech Investing
Gelesis Announces First U.S. Patient Enrolled in Pivotal Gelesis100 Weight-Loss Study Biotech Investing
Naturally Splendid Attends International Trade Shows and Presents in Geneva at NutraIngredients Awards Biotech Investing
Gradalis, Inc. Announces Initiation of a Phase 2 Study using Gradalis’ Vigil® Immunotherapy in Combination with Anti-PD-1 Technology to Treat Patients with Advanced Non-Small Cell Lung Cancer Biotech Investing
